Zeming Fu

Statistics

Publications

Citations

H-Index

Active since

2019

Affiliations

Second Affiliated Hospital of Jilin University(Current)

Zeming Fu is an author at Second Affiliated Hospital of Jilin University specializing in molecular oncology, noncoding rna in cancer, and microrna in cancer.

Publications per year

2019–2023

Publications

Long non-coding RNA ANRIL promotes proliferation, clonogenicity, invasion and migration of laryngeal squamous cell carcinoma by regulating miR-181a/Snai2 axis

Yanru Hao, Dejun Zhang, Zeming Fu et al. · Regenerative Therapy · 2019 · 34 citations · Full text

Medicine, Cancer Biology, Oncology +17

Circ_0000052/<scp>miR</scp>‐382‐3p axis induces <scp>PD‐L1</scp> expression and regulates cell proliferation and immune evasion in head and neck squamous cell carcinoma

Dejun Zhang, Zeming Fu, Yingyuan Guo et al. · Journal of Cellular and Molecular Medicine · 2022 · 25 citations · Full text

Medicine, Cancer Biology, Oncology +17

miR-488-3p sponged by circ-0000495 and mediated upregulation of TROP2 in head and neck squamous cell carcinoma development

Yanru Hao, Dejun Zhang, Yingyuan Guo et al. · Journal of Cancer · 2020 · 14 citations · Full text

Medicine, Cancer Biology, Oncology +17

Expression of PD‑L1 and CD4+ tumor‑infiltrating lymphocytes predict survival in head and neck squamous cell carcinoma

Zeming Fu, Dejun Zhang, Yingyuan Guo et al. · Molecular and Clinical Oncology · 2022 · 13 citations · Full text

Life Sciences, Immunology, Oncology +17

Luteolin inhibits the JAK/STAT pathway to alleviate auditory cell apoptosis of acquired sensorineural hearing loss based on network pharmacology, molecular docking, molecular dynamics simulation, and experiments in vitro

Fang Guo, Yingyuan Guo, Dejun Zhang et al. · Toxicology and Applied Pharmacology · 2023 · 11 citations

Medicine, Cell Biology, Pharmacology +14

1–5 of 5